MetLife, Inc. (NYSE:MET) Shares Bought by Kintegral Advisory LLC

Kintegral Advisory LLC boosted its stake in shares of MetLife, Inc. (NYSE:MET) by 42.6% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 57,527 shares of the financial services provider’s stock after acquiring an additional 17,198 shares during the period. Kintegral Advisory LLC’s holdings in MetLife were worth $4,038,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in the stock. Checchi Capital Advisers LLC raised its position in shares of MetLife by 2.8% in the second quarter. Checchi Capital Advisers LLC now owns 7,193 shares of the financial services provider’s stock valued at $505,000 after buying an additional 195 shares during the last quarter. AustralianSuper Pty Ltd raised its position in shares of MetLife by 0.8% in the second quarter. AustralianSuper Pty Ltd now owns 2,063,607 shares of the financial services provider’s stock valued at $144,845,000 after buying an additional 16,985 shares during the last quarter. Atomi Financial Group Inc. raised its position in shares of MetLife by 30.0% in the second quarter. Atomi Financial Group Inc. now owns 4,217 shares of the financial services provider’s stock valued at $296,000 after buying an additional 974 shares during the last quarter. Cambridge Investment Research Advisors Inc. raised its position in shares of MetLife by 12.2% in the second quarter. Cambridge Investment Research Advisors Inc. now owns 92,596 shares of the financial services provider’s stock valued at $6,499,000 after buying an additional 10,057 shares during the last quarter. Finally, Atlantic Edge Private Wealth Management LLC raised its position in shares of MetLife by 1.9% in the second quarter. Atlantic Edge Private Wealth Management LLC now owns 15,336 shares of the financial services provider’s stock valued at $1,076,000 after buying an additional 285 shares during the last quarter. 89.81% of the stock is currently owned by institutional investors and hedge funds.

MetLife Trading Up 1.0 %

MET stock traded up $0.73 during mid-day trading on Wednesday, hitting $75.75. 2,410,883 shares of the company were exchanged, compared to its average volume of 3,339,937. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.56. The firm has a market capitalization of $53.87 billion, a P/E ratio of 26.03, a PEG ratio of 0.65 and a beta of 1.05. The business has a fifty day simple moving average of $72.41 and a 200-day simple moving average of $71.65. MetLife, Inc. has a 12-month low of $57.91 and a 12-month high of $79.34.

MetLife (NYSE:MET) last announced its earnings results on Wednesday, July 31st. The financial services provider reported $2.28 earnings per share for the quarter, topping the consensus estimate of $2.13 by $0.15. The company had revenue of $17.82 billion during the quarter, compared to analyst estimates of $18.57 billion. MetLife had a net margin of 4.23% and a return on equity of 21.41%. MetLife’s revenue was up 7.2% compared to the same quarter last year. During the same quarter last year, the firm posted $1.94 earnings per share. On average, equities research analysts predict that MetLife, Inc. will post 8.62 earnings per share for the current fiscal year.

MetLife declared that its board has approved a stock buyback plan on Wednesday, May 1st that allows the company to repurchase $3.00 billion in shares. This repurchase authorization allows the financial services provider to buy up to 6% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company’s board believes its stock is undervalued.

MetLife Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 10th. Shareholders of record on Tuesday, August 6th will be paid a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a yield of 2.88%. The ex-dividend date of this dividend is Tuesday, August 6th. MetLife’s dividend payout ratio (DPR) is presently 74.91%.

Wall Street Analyst Weigh In

MET has been the subject of a number of recent research reports. Morgan Stanley reduced their target price on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating for the company in a research report on Monday, August 19th. Bank of America dropped their price objective on shares of MetLife from $99.00 to $96.00 and set a “buy” rating for the company in a report on Thursday, August 1st. Jefferies Financial Group upped their price objective on shares of MetLife from $83.00 to $86.00 and gave the company a “buy” rating in a report on Thursday, July 18th. Keefe, Bruyette & Woods dropped their price objective on shares of MetLife from $86.00 to $85.00 and set an “outperform” rating for the company in a report on Monday, July 8th. Finally, Piper Sandler dropped their price objective on shares of MetLife from $85.00 to $82.00 and set an “overweight” rating for the company in a report on Monday, May 6th. One research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $83.00.

MetLife Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.